114 related articles for article (PubMed ID: 8672929)
1. [Detection of genetic alterations in sporadic breast tumors].
Schmutzler RK; Homann A; Bierhoff E; Wiestler OD; von Daimling A; Krebs D
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():63-7. PubMed ID: 8672929
[TBL] [Abstract][Full Text] [Related]
2. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.
Niederacher D; Picard F; van Roeyen C; An HX; Bender HG; Beckmann MW
Genes Chromosomes Cancer; 1997 Mar; 18(3):181-92. PubMed ID: 9071571
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.
Silva JM; Gonzalez R; Provencio M; Dominguez G; Garcia JM; Gallego I; Palacios J; España P; Bonilla F
Breast Cancer Res Treat; 1999 Jan; 53(1):9-17. PubMed ID: 10206068
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
Beckmann MW; Picard F; An HX; van Roeyen CR; Dominik SI; Mosny DS; Schnürch HG; Bender HG; Niederacher D
Br J Cancer; 1996 May; 73(10):1220-6. PubMed ID: 8630282
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
6. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
7. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.
Nagahata T; Hirano A; Utada Y; Tsuchiya S; Takahashi K; Tada T; Makita M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
Breast Cancer; 2002; 9(3):208-15. PubMed ID: 12185331
[TBL] [Abstract][Full Text] [Related]
8. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.
van den Berg J; Johannsson O; Håkansson S; Olsson H; Borg A
Br J Cancer; 1996 Nov; 74(10):1615-9. PubMed ID: 8932343
[TBL] [Abstract][Full Text] [Related]
9. Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2.
Johnson SM; Shaw JA; Walker RA
Int J Cancer; 2002 Mar; 98(2):205-9. PubMed ID: 11857409
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
[TBL] [Abstract][Full Text] [Related]
11. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
13. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer.
Nowacka-Zawisza M; Forma E; Walczak M; Różański W; Bryś M; Krajewska WM
Med Oncol; 2015 Nov; 32(11):246. PubMed ID: 26433958
[TBL] [Abstract][Full Text] [Related]
16. Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomas.
Rhiem K; Todt U; Wappenschmidt B; Klein A; Wardelmann E; Schmutzler RK
Anticancer Res; 2010 Sep; 30(9):3445-9. PubMed ID: 20944121
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations.
Gudmundsson J; Barkardottir RB; Eiriksdottir G; Baldursson T; Arason A; Egilsson V; Ingvarsson S
Br J Cancer; 1995 Sep; 72(3):696-701. PubMed ID: 7669583
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy.
Watatani M; Nagayama K; Imanishi Y; Kurooka K; Wada T; Inui H; Hirai K; Ozaki M; Yasutomi M
Breast Cancer Res Treat; 1993 Dec; 28(3):231-9. PubMed ID: 7912561
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.
Gao X; Zacharek A; Salkowski A; Grignon DJ; Sakr W; Porter AT; Honn KV
Cancer Res; 1995 Mar; 55(5):1002-5. PubMed ID: 7866981
[TBL] [Abstract][Full Text] [Related]
20. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F
Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
